CAS: 312-93-6; Dexamethasone Phosphate (Ep Impurity C)

该化合物是一种合成的花生体,是三甲麻酮的衍生物,主要用于抗炎和免疫抑制特性,其特点是磷酸酯形式,与母体化合物相比,增加了水溶性;这种溶解性使其适合于亲生管理;该物质经常用于各种条件的治疗,包括过敏,自动免疫紊乱和某些类型的癌症;对甘油受体具有约束力,从而导致基因表达的调节和随后的炎症和免疫反应的减少,从而导致基因表达和随后的炎症和免疫反应的减少;其致癌性包括快速吸收和相对较长的半衰期,从而能够进行有效的治疗剂量;其常见的副作用可能包括增加对感染的敏感性,液体留存和葡萄代谢性的变化;与其他园类固醇一样,审慎监测对于减轻潜在的不利影响至关重要,特别是在长期使用的情况下,尤其对于减轻潜在的不利影响.

结构式图片

欧盟法规

REACH注册ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号50-02-2 地塞米松

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-11850220-B2
    优先权日:2020-05-19
    标题 :Synthesis of ibuprofen hybrid conjugates as anti-inflammatory and analgesic agents
    发明人:PANDA SIVA
    权利人:UNIV RES INST INC AUGUSTA
    摘要:Disclosed herein as ibuprofen hybrid conjugates and methods of their use to reduce inflammation, pain, and fever. The ibuprofen conjugates have potent anti-inflammatory and analgesic properties with low potential for ulcerogenic activity. An exemplary compound is an ibuprofen-amino acid-4-aminophenol hybrid. Also disclosed are methods of treating or reducing inflammation, pain, and fever in a subject.

    专利号:WO-9925385-A1
    优先权日:1997-11-17
    标 题:A method of increasing nucleic acid synthesis with ultrasound
    发明人:UNGER EVAN C; MCCREERY THOMAS; SADEWASSER DAVID
    权利人:IMARX PHARMACEUTICAL CORP
    摘要:The present invention is directed to a method of increasing nucleic acid synthesis in a cell comprising administering to the cell a therapeutically effective amount of ultrasound for a therapeutically effective time such that said administration of said ultrasound results in said increased nucleic acid synthesis. The nucleic acid sequence may comprise an endogenous sequence or an exogenous sequence.

    专利号:US-2013261317-A1
    优先权日:2010-09-27
    标题 :Methods for preparing synthetic bile acids and compositions comprising the same
    发明人:MORIARTY ROBERT M; RAO PHOTON
    权利人:MORIARTY ROBERT M; RAO PHOTON; KYTHERA BIOPHARMACEUTICALS INC
    摘要:This invention relates generally to methods for preparing certain bile acids from non-mammalian sourced starting materials as well as to synthetic bile acids and compositions comprising such acids wherein the acids are characterized by a different C 14 population than naturally occurring bile acids as well as being free from any mammalian pathogens. This invention is also directed to the synthesis of intermediates useful in the synthesis of such bile acids. Accordingly, the C ring of the steroidal scaffold is oxidized to provide a synthetic route and intermediates to DCA. This invention also provides synthetic methods for preparing deoxycholic acid or a salt thereof starting from aromatic steroids such as estrogen, equilenin, and derivatives thereof. This invention is also directed to intermediates such as 12-oxo or delta-9,11-ene steroids as well as novel processes for their preparation. In preferred embodiments, bile acids are provided herein which have substituents on the B-ring and/or D-ring side chain and optionally on the hydroxy group of the A-ring.

    专利号:US-5922335-A
    优先权日:1995-05-15
    标 题:Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
    发明人:PTCHELINTSEV DMITRI
    权利人:AVON PROD INC
    摘要:Novel uses of 3'-(L-ascorbyl-2-o-phosphoryl)-cholesterol, 3'-(L-ascorbyl-3-o-phosphoryl)-cholesterol, structural or functional isomers thereof and salts thereof (referred to collectively as 'APC compounds') are disclosed. Such novel uses include a method of reducing epidermal synthesis of abnormal elastin, especially epidermal synthesis of abnormal elastin that results from exposure to UV radiation. Also disclosed is a novel method of stimulating keratinocyte formation of triglycerides. In addition, a novel method of achieving antioxidant activity, both in the skin and also in topical compositions, is disclosed.

    专利号:US-6150403-A
    优先权日:1997-10-14
    标 题 :Topical compositions for regulating the oily/shiny appearance of skin
    发明人:BIEDERMANN KIMBERLY A; SCHUBERT HARRY L; PARRAN JR JOHN J
    权利人:PROCTER & GAMBLE
    摘要:The present invention relates to methods for inhibiting sebaceous gland activity in mammalian skin comprising administration of a topical composition comprising dehydroacetic acid or pharmaceutically acceptable salts thereof, and a dermatologically-acceptable carrier. The present invention also relates to methods and topical compositions further comprising agents which regulate the oily and/or shiny appearance of skin, and agents which treat acne and related skin disorders in mammalian skin and scalp. Methods of reducing sebum synthesis with the use of dehydroacetic acid, methods of regulating the oily and/or shiny appearance of skin, and methods of treating acne and other skin disorders are also encompassed by the present invention.

    专利号:US-2024409557-A1
    优先权日:2023-05-09
    标 题 :5,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulators
    发明人:GREENMAN KEVIN LLOYD; PICKRELL ALEXANDER J; LI KEXUE; AMEGADZIE ALBERT K; WANG HUI-LING; WEIRES NICHOLAS ANTHONY; ALLEN JOHN G; BOURBEAU MATTHEW P
    权利人:AMGEN INC
    摘要:The present disclosure provides novel 15-hydroxy-prostaglandin dehydrogenase inhibitors, pharmaceutical compositions comprising such compounds, and methods of using such compounds and compositions in treating 15-hydroxy-prostaglandin dehydrogenase-mediated disease. Also provided are methods of making such compounds and intermediates thereof. The compounds have a general Formula (A).Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (A).

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Sinner B. Perioperatives Dexamethason [Perioperative dexamethasone]. Anaesthesist. 2019 Oct;68(10):676-682. German. doi: 10.1007/s00101-019-00672-x. 6(1):51. doi: 10.1186/s40425-018-0371-5.
    3: Madamsetty VS, Mohammadinejad R, Uzieliene I, Nabavi N, Dehshahri A, García- Couce J, Tavakol S, Moghassemi S, Dadashzadeh A, Makvandi P, Pardakhty A, Aghaei Afshar A, Seyfoddin A. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS Biomater Sci Eng. 2022 May 9;8(5):1763-1790. doi: 10.1021/acsbiomaterials.2c00026. Epub 2022 Apr 19.
    38:246-263. doi: 10.22203/eCM.v038a17.

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    参考文献:10.3109/02652049609026039
    摘要:Farshi FS, Özerk AY, Ercan MT, Hincal AA. In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate. Journal of Microencapsulation. 1996 Jan;13(5):537–44. doi: 10.3109/02652049609026039.
    参考文献:10.1186/1465-9921-5-4
    摘要:Clayton RA, Dick CA, Mackenzie A, Nagasawa M, Galbraith D, Hastings SF, MacKenzie SJ. The effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthma. Respiratory Research. 2004 May 05;5(1):4. doi: 10.1186/1465-9921-5-4.
    摘要:Chen G, Hou SX, Liu J, Luan JG, Zhang Y. [In vivo distribution and pharmacokinetics of dexamethasone sodium phosphate thermosensitive in situ gel following intratympanic injection]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 May;37(3):456–9.
    参考文献:10.1093/annonc/mdl127
    摘要:Kahl BS, Longo WL, Eickhoff JC, Zehnder J, Jones C, Blank J, McFarland T, Bottner W, Rezazedeh H, Werndli J, Bailey HH; Wisconsin Oncology Network. Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. Ann Oncol. 2006 Sep;17(9):1418–23. doi: 10.1093/annonc/mdl127.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知